Literature DB >> 23201469

Mirabegron as a new class of oral drug for overactive bladder syndrome: many positive perspectives, some concerns.

Giacomo Novara, Jean-Nicolas Cornu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23201469     DOI： 10.1016/j.eururo.2012.11.024

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

1.  Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real-world claims data analysis.

Authors:  D Sussman; A Yehoshua; J Kowalski; W Lee; J Kish; S Chaudhari; B Murray
Journal:  Int J Clin Pract       Date:  2017-03       Impact factor: 2.503

2.  Postmenopausal overactive bladder.

Authors:  Jacek Tomaszewski
Journal:  Prz Menopauzalny       Date:  2014-12-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.